Mizuho's Top Stock Picks For November Revealed
Mizuho's Top Stock Picks For November Revealed
As trading for November begins, Mizuho recommends a few stocks for investors to consider. The Dow Jones, S&P 500, and Nasdaq Composite have all registered gains, marking a shift from October's downturn.
随着11月交易的开始， 瑞穗市 推荐几只股票供投资者考虑。道琼斯指数、标准普尔500指数和纳斯达克综合指数均上涨，这标志着10月份的低迷有所转变。
According to CNBC, Mizuho's equity research team has put together its top buy-rated picks for November. The list includes new names like Coterra Energy Inc (NYSE:CTRA), Merck & Co. (NYSE:MRK), EyePoint Pharmaceuticals (NASDAQ:EYPT) and Intuit (NASDAQ:INTU).
据CNBC报道，瑞穗的股票研究团队已经汇总了11月份买入评级最高的精选。该列表包括新名字，例如 Coterra 能源公司 （纽约证券交易所：CTRA）， 默沙东公司 （纽约证券交易所：MRK）， EyePoint （纳斯达克股票代码：EYPT）和 Intuit （纳斯达克股票代码：INTU）。
Despite a Wall Street average rating of "hold" for Coterra, Mizuho is bullish on the stock, which is already up about 14% this year. Analyst Nitin Kumar points to the company's potential upside and its peer-leading cash return framework as reasons for optimism.
尽管华尔街对Coterra的平均评级为 “持有”，但瑞穗仍看好该股，该股今年已经上涨了约14％。分析师尼廷·库马尔指出，该公司的潜在上行空间及其同行领先的现金回报框架令人乐观。
See Also: Barron's Weekend Stock Picks: Chevron, Apple, Disney And Insulet's Stock Increase
另见：《巴伦周末》股票精选：雪佛龙、苹果、迪士尼和Insulet的股票上涨
Mizuho is also positive about Merck, despite a nearly 7% dip in its stock this year. Analyst Mara Goldstein cites the company's promising pharmaceutical pipeline as a key growth driver.
尽管今年默沙东的股价下跌了近7％，但瑞穗也对默沙东持乐观态度。分析师玛拉·戈德斯坦指出，该公司前景广阔的制药产品线是关键的增长动力。
EyePoint Pharmaceuticals, whose shares have risen over 120% this year, is also on Mizuho's radar. Analyst Graig Suvannavejh highlights the company's focus on less frequently administered eye therapies as its unique selling point.
EyePoint Pharmicals的股价今年已上涨120％以上，也受到瑞穗的关注。分析师Graig Suvannavejh强调，该公司将重点放在使用频率较低的眼科疗法上，这是其独特的卖点。
The last on the list, Intuit, is touted as a potential artificial-intelligence winner. Analyst Siti Panigrahi notes the company's defensible business model and its strong track record of growth.
名单上的最后一位Intuit被吹捧为潜在的人工智能赢家。分析师西蒂·帕尼格拉希指出，该公司具有防御能力的商业模式及其强劲的增长记录。
The stocks of the four companies are anticipated to see further growth, with Mizuho's analysts offering optimistic projections for each.
预计这四家公司的股票将进一步增长，瑞穗的分析师对每家公司都给出了乐观的预测。
The full list is below, along with the average rating via LSEG and the upside/downside to the average price target (%) via LSEG:
完整列表如下，以及伦敦证券交易所的平均评级以及伦敦证券交易所平均目标价（％）的上行/下行空间：
- Coterra Energy: Hold; 15.5
- Merck & Co: Buy; 20.9
- EyePoint Pharmaceuticals: Buy; 289.9
- Intuit: Buy, 13.5
- Mondelez International Inc (NASDAQ:MDLZ): Buy; 16.0
- DTE Energy Co (NYSE:DTE): Buy; 10.3
- Pentair PLC (NYSE:PNR): Buy; 20.4
- Omega Healthcare Investors Inc (NYSE:OHI): Hold; 8.1
- Amazon.com Inc (NASDAQ:AMZN): Buy; 24.4
- Nvidia Corp (NASDAQ:NVDA): Buy; 39.6
- 科特拉能源: 按住；15.5
- 默克公司: 购买；20.9
- EyePoint: 购买；289.9
- 直觉： 购买，13.5
- Mondelez 国际公司 （纳斯达克股票代码：MDLZ）：买入；16.0
- DTE 能源公司 （纽约证券交易所：DTE）： 购买；10.3
- Pentair PLC （纽约证券交易所代码：PNR）：买入；20.4
- 欧米茄医疗投资公司 （纽约证券交易所代码：OHI）：Hold；8.1
- 亚马逊公司 （纳斯达克股票代码：AMZN）：买入；24.4
- 英伟达公司 （纳斯达克股票代码：NVDA）： 购买；39.6
Read Next: This Week In Apple: iPhone 16 Expectations, Wall Street's Overreaction On Q4 Guidance And More
继续阅读：本周苹果报道：iPhone 16的预期、华尔街对第四季度指引的过度反应等等
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
该内容部分是在人工智能工具的帮助下制作的，并由Benzinga编辑审查和发布。
Photo: Shutterstock
照片：Shutterstock